Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview
- 10 November 2009
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 61 (6) , 842-846
Abstract
Despite the use of surgical resection and aggressive chemotherapy, nearly 50% of patients with colorectal carcinoma develop recurrent disease, highlighting the need for improved therapies. Curcumin (diferuloylmethane), the major active ingredient of turmeric (curcuma longa) with no discernable toxicity, has been shown to inhibit the growth of transformed cells and colon carcinogenesis at the initiation, promotion, and progression stages in carcinogen-induced rodent models. In a Phase I clinical trial, curcumin has been found to be extremely well tolerated and effective. In this review, we summarized the current status of our knowledge about the effectiveness of curcumin when given in combination with current chemotherapeutics such as 5-fluorouracil, oxaliplatin, and gemcitabine in treatment of gastrointestinal cancers with particular reference to colorectal cancer. Existing data suggest that curcumin in combination with chemotherapy is a superior strategy for treatment of gastrointestinal cancer.Keywords
This publication has 38 references indexed in Scilit:
- Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancerBMC Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Curcumin Augments Gemcitabine Cytotoxic Effect on Pancreatic Adenocarcinoma Cell LinesCancer Investigation, 2007
- Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulationCarcinogenesis, 2006
- RIα influences cellular proliferation in cancer cells by transporting RFC40 into the nucleusCancer Biology & Therapy, 2005
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Microsatellite Instability as a Marker in Predicting Metachronous Multiple Colorectal Carcinomas After SurgeryDiseases of the Colon & Rectum, 2002
- Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin☆☆☆Gastroenterology, 1998
- Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermisCarcinogenesis, 1997
- Studies on Crude Drugs Effective on Visceral Larva Migrans. Part XVI. Nematocidal Activity of Turmeric: Synergistic Action of Curcuminoids.Chemical and Pharmaceutical Bulletin, 1993